Detection of Nonhematologic Neoplasms by Routine Flow Cytometry Analysis
Joseph Annunziata1,2, Michael L Miller1,2, David C Park1,2
1Department of Pathology and Cell Biology, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY.
American Journal of Clinical Pathology
|October 7, 2019
Summary
Routine flow cytometry (FC) can detect nonhematologic neoplasms (non-HN) using standard hematologic panels. Careful review of CD45-negative events aids in identifying these diverse cancers.
Area of Science:
- Immunology
- Oncology
- Pathology
Background:
- Flow cytometry (FC) is a standard diagnostic tool for hematologic neoplasms.
- Nonhematologic neoplasms (non-HN) are typically diagnosed using different methods.
- The potential of routine FC panels to detect non-HN is underexplored.
Purpose of the Study:
- To evaluate the efficacy of standard hematologic flow cytometry antibody panels in detecting nonhematologic neoplasms.
- To identify non-HN within diagnostic samples using CD45-negative event analysis.
- To assess the frequency and types of non-HN detectable by routine FC.
Main Methods:
- Retrospective review of 4,000 diagnostic FC analyses.
- Identification of aberrant, viable CD45-negative neoplastic populations.
- Utilized antibody panels routinely employed for hematologic neoplasm diagnosis.
Main Results:
- 57 diverse non-HNs (1.4%) were identified.
- Neuroendocrine tumors (33/57) and carcinomas (9/57) were the most common types.
- CD56 (84.3%), CD117 (44.1%), and CD138 (18.2%) were frequently expressed markers.
Conclusions:
- Routine flow cytometry can identify nonhematologic neoplasms.
- Careful inspection of CD45-negative events is crucial for non-HN detection.
- This approach can expedite further diagnostic workup for non-HN.
Keywords:
CD117CD138CD56CarcinomaFlow cytometryNeuroendocrineNonhematologic malignanciesNonhematologic neoplasmsMore Related Videos
12:05Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation
Published on: November 3, 2018
12.2K
05:24Two Flow Cytometric Approaches of NKG2D Ligand Surface Detection to Distinguish Stem Cells from Bulk Subpopulations in Acute Myeloid Leukemia
Published on: February 21, 2021
4.6K
